Coronavirus pneumonia is accompanied by rapid virus replication, where a large number of
inflammatory cell infiltration and cytokine storm may lead to acute lung injury, acute …

Background Mesenchymal stromal cells (MSCs) demonstrate considerable promise in
preclinical acute respiratory distress syndrome models. We wished to determine the efficacy and …

Background: Mesenchymal stromal cells (MSCs) have been demonstrated to attenuate acute
lung injury when delivered by intravenous or intratracheal routes. The authors aimed to …

Editor’s Perspective What We Already Know about This Topic Mesenchymal stromal cells
are multipotent adult stem cells with the capacity to differentiate into multiple cell types and …

Objective: Although mesenchymal stem/stromal cells represent a promising therapeutic
strategy for acute respiratory distress syndrome, clinical translation faces challenges, including …

Background The potential for mesenchymal stem cells (MSCs) to reduce the severity of
experimental lung injury has been established in several pre-clinical studies. We have recently …

The mechanisms of action of hypercapnia and acidosis continue to be elucidated, and this
knowledge is central to determining the safety and therapeutic utility of hypercapnia in …

Background: Rodent mesenchymal stem/stromal cells (MSCs) enhance repair after
ventilator-induced lung injury (VILI). We wished to determine the therapeutic potential of human …

Acute respiratory distress syndrome (ARDS) is driven by a severe pro-inflammatory response
resulting in lung damage, impaired gas exchange and severe respiratory failure. There is …

Rationale We wished to determine the influence of sex on the management and outcomes
in acute respiratory distress syndrome (ARDS) patients in the Large Observational Study to …